Table 1:

Characteristics of study cohort by variant of concern status

VariableNo. (%) of patients*p value
Total
n = 212 326
VOC not detected
n = 43 417
N501Y-positive VOC
n = 162 920
Probable Delta VOC
n = 5989
Hospitalized11 038 (5.2)1914 (4.4)8775 (5.4)349 (5.8)< 0.001
Admitted to ICU2324 (1.1)337 (0.8)1897 (1.2)90 (1.5)< 0.001
Died1820 (0.9)384 (0.9)1396 (0.9)40 (0.7)0.23
Sex, male107 582 (50.7)22 023 (50.7)82 505 (50.6)3054 (51.0)0.84
Age, yr< 0.001
 < 1015 266 (7.2)3016 (6.9)11 732 (7.2)518 (8.6)
 10–1925 390 (12.0)5209 (12.0)19 508 (12.0)673 (11.2)
 20–2943 648 (20.6)8612 (19.8)33 640 (20.6)1396 (23.3)
 30–3935 983 (16.9)7117 (16.4)27 768 (17.0)1098 (18.3)
 40–4931 768 (15.0)6198 (14.3)24 769 (15.2)801 (13.4)
 50–5929 972 (14.1)6287 (14.5)22 920 (14.1)765 (12.8)
 60–6918 108 (8.5)3971 (9.1)13 664 (8.4)473 (7.9)
 70–798018 (3.8)1892 (4.4)5944 (3.6)182 (3.0)
 ≥ 804173 (2.0)1115 (2.6)2975 (1.8)83 (1.4)
Vaccination status
 Partially vaccinated72 838 (34.3)169 327 (39.0)54 211(33.3)1700 (28.4)< 0.001
 Fully vaccinated945 (0.4)142 (0.3)732 (0.4)71 (1.2)< 0.001
Comorbidity10 805 (5.1)2940 (6.8)7547 (4.6)318 (5.3)< 0.001
Pregnant555 (0.3)124 (0.3)410 (0.2)21 (0.4)0.18
Geography
 GTHA§156 804 (73.9)27 535 (63.4)125 380 (77.0)3889 (64.9)< 0.001
 Ottawa9325 (4.4)1874 (4.3)7334 (4.5)117 (2.0)< 0.001
  • Note: GTHA = Greater Toronto and Hamilton Area, ICU = intensive care unit, VOC = variant of concern.

  • * Unless indicated otherwise.

  • p values based on χ2 test.

  • Comorbidities include 1 or more of asthma, chronic obstructive pulmonary disease, hematological disease, liver disease, cardiac disease, diabetes, immune compromise, renal disease, neurologic disease, malignancy, or obesity.

  • § Large conurbation in Central Ontario consisting of 6 health units (Toronto, Peel, Durham, Halton, York and Hamilton).